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Clinical pain testing has been used to ascertain the pathophysiology of many 
clinical conditions, but its use in the management of endometriosis has been lim-
ited. Although the testing can require the use of complex testing in the laboratory, 
this chapter is directed to look at a test for allodynia that can be applied in the clinic. 
The test for cutaneous allodynia is validated, does not require sophisticated tools, 
and is readily accepted by woman. The presence of allodynia in certain gynecologi-
cal presentations can indicate the woman’s pain system has become sensitized. Uses 
of the test in clinical encounters with women suffering from endometriosis and 
possible uses in future are presented.
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1. Introduction
The object of this chapter is to introduce and describe pain testing for gynecolo-
gists to use at the bedside. Although the subject’s description of pain is still the best 
method of assessing pain, the use of objective pain measures permit independent 
quantification that is useful in explaining a more complete picture of a disease 
process, and it is also of help in documenting change in response to medical or 
surgical intervention. Formal pain testing has now provided new information 
on the pain mechanisms in chronic pancreatitis, dysmenorrhea, painful bladder 
syndrome, osteoporosis, and low back pain to name a few conditions [1–5]. Central 
sensitization has been identified as a component of persistent pelvic pain, with and 
without endometriosis [3–5]. This summary is intended to provide several examples 
where testing gives both the woman and the gynecologist a fuller appreciation of 
the clinical problem of pain.
Clinical pain testing has been used to ascertain the pathophysiology of many 
clinical conditions, but its use in the management of endometriosis has been limited. 
Although the testing can require the use of complex testing in the laboratory, this 
chapter is directed to look at a test for allodynia that can be applied in the clinic. The 
test for cutaneous allodynia is validated, does not require sophisticated tools, and is 
readily accepted by woman. The presence of allodynia in certain gynecological pre-
sentations can indicate the woman’s pain system has become sensitized. Uses of the 
test in clinical encounters with women suffering from endometriosis and possible 
uses in future are presented.
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2. Visceral pain physiology
The physiological basis for pain testing is viscero-somatic pain referral. One 
of the first such observations was made by Sir James Mackenzie (1853–1925). 
Although known primarily for his work on cardiac physiology, arrhythmias, and 
heart disease, he wrote a book in 1913 that provides insight into how we might 
understand the clinical signs of pelvic disease [6]. Mackenzie provided a diagram 
of a man with biliary colic who had pain radiating to his right upper quadrant 
(Figure 1). This painful area was also found to have an area of allodynia in the same 
area. Allodynia is defined as pain from a non-painful source. The allodynia can 
be static or dynamic depending on the mode of testing. Static allodynia is direct 
pressure on the skin, while dynamic allodynia uses movement across the affected 
area. Notably, Mackenzie found a small area within the region of allodynia that was 
particularly tender and corresponded to the anterior cutaneous nerve that passed 
through the abdominal wall fascia. Mackenzie correctly noted that not only the 
colicky pain was referred to the right upper quadrant but also there was also a tiny 
muscular component of this referral, centered on the tender ninth thoracic nerve as 
it perforates the abdominal wall fascia.
This simple diagram is the basis for the clinical testing of women’s pelvic pain at 
the bedside. Most of the causes of pain in the pelvis associated with endometriosis 
are due to inflammatory processes. These are considered nociceptive influences on 
the afferent nervous system that pass to the spinal cord primarily in the T12 and L1 
segments. The viscero-somatic referral then initiates efferent activity through the 
corresponding anterior cutaneous nerves to the lower abdomen. The result of the 
efferent activity is the pattern of allodynia and tender areas in a similar fashion to 
Mackenzie (Figure 1). There are many variations of the presentation, unilateral, 
bilateral, with both equal and unequal sizes of the allodynia [6].
Another contributor was Sir Henry Head (1861–1940) who, mapped out the 
referral patterns of the body of many illnesses that initially became the Head zones 
but later evolved to be the dermatomes. The accompanying figure demonstrates the 
ovarian zones (Figure 2) [7].
Figure 1. 
Location of right upper quadrant allodynia associated with tenderness in the region of ninth anterior cutaneous 
nerve due to biliary colic.
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More recent studies of the visceral-somatic referral and guidelines for the 
management of associated persistent pain have been reported [8–12].
3. Detection of allodynia and expansion
To detect allodynia, a cotton-tipped applicator is slowly drawn down from 
the midclavicular line toward the pubic region along the imagined border of 
the rectus abdominus muscle. It is necessary to start the test outside the area of 
allodynia. Starting within will not detect the necessary changes. As the appli-
cator is positioned, the woman is asked to note if there is any sudden change 
in sensation or the onset of a sharp pain. When this is announced, the level is 
marked off with a body marker. An example of two small areas of allodynia 
containing trigger points associated with the T12 anterior cutaneous nerves is 
shown in Figure 3.
An extreme example of severe chronic pelvic pain demonstrates how large the 
area of allodynia can become—this degree is unusual (Figure 4). The delineation of 
allodynia that is marked off with a pen can stimulate spinal activity such that there 
is an almost immediate shift in the borders of allodynia (Figure 4). These shifts 
in the levels of sensation correspond to “jumps” taking place in the spinal cord, 
segment by segment.
Figure 2. 
Demonstration of the Head zones.
Figure 3. 
Small areas of allodynia containing painful trigger points of T12 anterior cutaneous nerves.
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4. Hyperalgesia and location of trigger points on the abdomen
Associated with the allodynia, one can determine the presence of hyperalgesia, 
which is an increased pain sensation from a painful source. The examining finger 
can detect this when gently applied to the area (Figure 5). The examination has 
to be gentle as a pressure of only 15–20 g can evoke severe pain from the small 
nodular trigger point (Figure 5). The location of the trigger point has been marked 
in Figure 6.
A more sophisticated way of determining the degree of hyperalgesia is with an 
algometer. This instrument will determine the pressure pain threshold. Measures 
of pressure pain thresholds are reduced in the areas affected by pain sensitization. 
In many cases of severe chronic pelvic pain, it is possible to put only the mildest 
Figure 4. 
An example of allodynia expansion upward by dermatome with each test for allodynia in a woman with severe 
pelvic pain.
Figure 5. 
Localizing a viscerally related trigger point with gentle pressure from the pulp of the examining finger.
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pressure in the region of the anterior cutaneous nerve to have the induced pain 
threshold recorded.
5. Validity of allodynia testing in pelvic pain
In order to have faith in allodynia, it is important to ensure the test has reliability. 
In a cohort of 81 women with chronic pelvic pain, the presence of allodynia was 
significantly associated with those who were suffering from visceral disease [13].
The positive predictive values for pelvic visceral disease were as follows:
Abdominal cutaneous allodynia 93%
Perineal cutaneous allodynia 91%
Abdominal myofascial trigger points 93%
Perineal myofascial trigger points 81%
Reduced pain thresholds 79%
The likelihood ratio (+) and 95% C.I. for the detection of visceral sources of pain 
were as follows:
Abdominal cutaneous allodynia 4.19 (1.46, 12.0)
Perineal cutaneous allodynia 2.91 (1.19, 7.11)
Abdominal myofascial trigger points 4.19 (1.46, 12.0)
Pelvic myofascial trigger points 1.35 (0.86, 2.13)
Reduced pain thresholds 1.14 (0.85, 1.52), [13]
In another study of validity, a total of 22 females with chronic pelvic pain were 
compared to 23 pain-free controls and 12 cyclic pain patients. Participants were 
evaluated by two clinicians. Investigators mapped the abdomen with the cotton-
tipped applicator, outlined the areas of allodynia with a body pen, photographed 
the abdomen, and wiped off the marking before the second investigator repeated 
the test. The interrater reliability resulted in 98% agreement for the three study 
Figure 6. 
The location of the trigger point corresponds to the right anterior cutaneous nerve from T12 spinal nerve.
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groups. The cotton-tipped applicator test showed 73% sensitivity and 100% 
specificity for differentiating patients with chronic pelvic pain from pain-free 
patients [14]. At present, there do not appear to be pain-testing techniques that 
specifically identify endometriosis independent from other visceral diseases. 
It is arguable, however, that the experience of pain may have greater relevance 
depending on the clinical situation as described in relation to the negative 
laparoscopy.
6. The negative laparoscopy
A comparison of the results of pain testing was done in women investigated 
for pelvic pain between 69 with confirmed endometriosis compared to 35 who 
had a negative laparoscopy [15]. When women with a negative laparoscopy were 
compared to those with confirmed endometriosis, there were no differences in age, 
gravidity, parity, menarche, and frequency of dyspareunia or duration of severe 
dysmenorrhea. There were no differences in the frequency of abdominal wall 
allodynia or of pressure pain thresholds. These tests give validation to the women 
who otherwise have no explanation and it also raises the possibility that dysmenor-
rhea may be the source of the pelvic pain. These results are consistent with testing 
of women with persistent pelvic pain with and without endometriosis [3].
7. Prediction of postoperative pain
There has been a great deal of interest in the prediction of postoperative pain, 
but most of the studies have not included laparoscopic pelvic surgery. The situation 
is very complex with a wide number of variables having a role such as preopera-
tive pain, depression, previous surgery, gender, and opiate use and abuse. A study 
of the assessment of predicting postoperative pain considered these elements but 
also included testing for the presence of allodynia and hyperalgesia before and 
after 6 months following laparoscopic surgery for non-acute pain. Hyperalgesia 
was identified with the use of a Somedic Algometer (Somedic SenseLab AB, Norra 
Mellby 1129 SE-280 10 Sösdala, Sweden). In women who underwent tubal ligation, 
pain levels were low before and after the procedure. In 61 women who underwent 
surgery for non-acute pain, pain levels at 6 months and all psychologic test scores 
were reduced significantly compared with baseline (P < .001 and P = .001, respec-
tively). Among those women with positive results on the quantitative pain tests of 
sensitization at baseline, average postoperative pain was also significantly reduced 
(P < .001). Univariate analysis demonstrated only tests of sensitization were cor-
related with the reduction in average pain level (P = .01). Regression analysis sug-
gested that baseline pain, catastrophizing, and the presence of cutaneous allodynia 
significantly predicted pain levels after 6 months. We had anticipated sensitization 
would have predicted more pain, but we have interpreted the results to indicate 
the reduction in pain may be due to the successful removal of a nociceptive source 
in the pelvis. At present, pain testing does not indicate whether surgery should or 
should not be done; that remains a clinical decision.
8. Detection of sensitization in relation to psychological status
Also, a secondary analysis reviewed the changes in pain and psychological mea-
sures of stress (Pain Disability Index, Pain Catastrophizing Scale, CES-D (Center 
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for Epidemiologic Studies Depression Scale)), depression scale, and the McGill Pain 
Scale (short form) as the presence of pain sensitization. Preoperatively, the psycho-
logical test scores correlated significantly with the pain scores. Post-laparoscopic 
surgery pain and psychosocial test scores were reduced and remained significantly 
correlated. The presence of preoperative pain sensitization was associated with 
trends to greater baseline and 6-month postoperative changes in average pain and 
measures of psychological distress [16].
9. Relationship to pelvic floor
In a study of 112 women with chronic pelvic pain assessed for pain in the abdominal 
wall, perineum, levator ani, and obturator internus, the number of myofascial trigger 
points was predicted by the number of previous laparoscopies adjusted for age. Both 
the presence of visceral disease and endometriosis were significantly associated with 
higher numbers of myofascial dysfunction than the absence of these conditions [17]. 
These findings suggested that prior surgery may aggravate pain sensitization. The 
available studies using pain testing do not indicate they can discriminate endometriosis 
from other visceral diseases [3, 13, 18]. It should also be noted here the test for allo-
dynia on the perineum was validated as noted above [13].
10. Possible future benefits of pain testing
It has long been known that the extent of disease does not have a correlation with 
the severity of pain. Many women with minimal disease are severely incapacitated 
with their pain. Alternatively, but less common, are women with severe stage 4 
disease without pelvic pain. Many gynecologists have seen women who have had 
repeated procedures for minimal disease despite having no change in their pain [18]. 
The techniques of pain testing can provide an assessment indicating peripheral and 
central sensitization have altered pain physiology and possibly eliminate the need 
for repetitive laparoscopic surgery of limited, if any, benefit.
There have been several blinded controlled trials of the excision versus sham 
excision of endometriosis for the management of pain [19–22]. The results have 
differed; in several, there was a reduction in pain; in another that was extended out 
14 years post-randomization, there was no difference between the sham excision 
and excision. Perhaps it may not be the surgeons’ expertise, the degree of disease, or 
prior pelvic surgery, but the differences may possibly be explained by the womens’ 
pain sensitization. Pain testing might have a unifying feature to allow comparisons 
of cohorts of subjects in clinical trials.
Many surgeons have had the unsettling experience of having one of their 
women undergo what is considered a straightforward operation of hysterectomy, 
tubal ligation, or laparoscopic excision of endometriosis in which the woman 
returns with severe incapacitating pelvic pain. The reason is not in the operative 
procedure that was uncomplicated, but it is difficult at times to persuade that to 
the woman involved. Possibly, there was a preexisting state that made this possible. 
In reviewing women presenting with postoperative onset of chronic pelvic pain, 
there is commonly a history of pain preceding the operation. This can take the form 
of severe dysmenorrhea, repetitive bouts of cystitis, or prior kidney stones. Pain 
causes chronic pain and while it is possible to generate chronic pelvic pain from an 
isolated procedure, it is much more common to see there was a previous pattern of 
repetitive pain. The shift to a chronic pain state might be identified as a risk with 
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Also, there is a troubling experience of undertaking an operative laparoscopy 
anticipating there is going to be endometriosis present and instead finding no 
disease whatsoever. Again, this leads to difficult explanations and often the patient 
will seek yet another laparoscopy.
These examples are fundamentally issues of pain and pain management. In order 
to have a strategy to inform these situations, pain testing might be of assistance.
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